Home / MissionIR Articles

MissionIR Articles

  • Matinas BioPharma Holdings, Inc. (MTNB) Utilizing Proprietary Technology to Improve Safety Profile of Existing Drugs

    Matinas Biopharma Holdings is a clinical-stage biopharmaceutical company focused on the development of safe and effective broad spectrum antifungal and anti-bacterial therapeutics for the treatment of serious and life-threatening infections. The company’s proprietary, disruptive technology…

  • Brainstorm Cell Therapeutics (BCLI) Presents at Rodman & Renshaw Conference

    Brainstorm Cell Therapeutics, Inc. (NASDAQ: BCLI)is developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases, e.g. Amyotrophic Lateral Sclerosis (ALS a.k.a. Lou Gehrig’s disease), Multiple Sclerosis (MS) and Parkinson’s disease (PD). NurOwn is…

  • BioTime (BTX) Presents at Rodman & Renshaw Conference

    BioTime, Inc. (NYSE: BTX) is building a dominant company in the field of regenerative medicine. The company’s strategy is to be the leader in the development of pluripotent stem cell-based technologies and to apply those…

  • Biota Pharmaceuticals (BOTA) Presents at Rodman & Renshaw Conference

    Biota Pharmaceuticals, Inc. (NASDAQ: BOTA) is focused on discovering and developing direct-acting antivirals to treat infections that affect a significant number of patients globally. The company has four product candidates with limited therapeutic options in…

  • BioSpecifics Technologies (BSTC) Presents at Rodman & Renshaw Conference

    BioSpecifics Technologies Corp. (NASDAQ: BSTC) is a profitable, commercial-stage biopharmaceutical company that has developed injectable collagenase for 12 clinical indications to date. Injectable collagenase is approved for marketing as XIAFLEX (collagenase clostridium histolyticum or CCH)…

  • BioPharmX (BPMX) Presents at Rodman & Renshaw Conference

    Through its patented platform technologies, BioPharmX Corporation (NYSE MKT: BPMX) develops unique health and wellness products for licensing and commercialization in pharmaceutical, over-the-counter and supplemental use. The BioPharmX team aims to touch lives by providing…

  • BiondVax Pharmaceuticals (BVXV) Presents at Rodman & Renshaw Conference

    BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), an innovative biopharmaceutical company, is developing a universal flu vaccine designed to provide multi-season and multi-strain protection against most human influenza virus strains, including both seasonal and pandemic flu strains.…

  • BioMark Diagnostics (BMKDF) Presents at Rodman & Renshaw Conference

    BioMark Diagnostics, Inc. (OTCQB: BMKDF) is an oncology-focused company on a mission to develop and market cutting-edge technologies to increase prediction and accuracy in the diagnosis of cancers. The company develops metabolomics-based diagnostic assays for…

  • BioLineRx (BLRX) Presents at Rodman & Renshaw Conference

    Israel-based BioLineRx Ltd. (NASDAQ: BLRX) is a clinical-stage biopharmaceutical company committed to identifying, in-licensing and developing promising therapeutic candidates. The company in-licenses novel compounds primarily from academic institutions and biotech companies based in Israel, develops…

  • BioLife Solutions (BLFS) Presents at Rodman & Renshaw Conference

    BioLife Solutions, Inc. (NASDAQ: BLFS) is located in Bothell, Washington, on a high-tech campus that has roots as a dairy farm. The company manufactures and markets proprietary protein-free, serum-free cGMP biopreservation media for cells, tissues…

  • Biocept (BIOC) Presents at Rodman & Renshaw Conference

    Biocept, Inc. (NASDAQ: BIOC) is developing innovative diagnostic solutions that give patients and doctors the information they need—all from a simple blood test known as a liquid biopsy. Biocept has now developed a unique, patented…

  • Bio-Path Holdings (BPTH) Presents at Rodman & Renshaw Conference

    Bio-Path Holdings, Inc. (NASDAQ: BPTH) is focused on developing therapeutic products that use its proprietary liposomal delivery technology, which is designed to systemically distribute nucleic acid drugs throughout the human body via a simple intravenous…

  • Bio Blast Pharma (ORPN) Presents at Rodman & Renshaw Conference

    Bio Blast Pharma Ltd. (NASDAQ: ORPN) is a clinical-stage biotechnology company committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. Established in 2012, the company is quickly building a diverse…

  • Bellerophon Therapeutics (BLPH) Presents at Rodman & Renshaw Conference

    Bellerophon Therapeutics LLC (NASDAQ: BLPH)is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Its mission is to develop well-studied molecules deployed…

  • Avita Medical (AVMXY) Presents at Rodman & Renshaw Conference

    Avita Medical Ltd. (OTC: AVMXY) develops and distributes regenerative products to treat a broad range of wounds, scars and skin defects. The company’s patented and proprietary collection and application technology provides innovative treatment solutions derived…

  • Avino Silver & Gold Mines (ASM) Presents at Rodman & Renshaw Conference

    Avino Silver & Gold Mines Ltd. (NYSE: ASM) is a Vancouver-based mining and exploration firm. Founded in 1968, Avino’s mission is to create shareholder value through profitable organic growth at the historic Avino property near…

  • Aurinia Pharmaceuticals (AUPH) Presents at Rodman & Renshaw Conference

    Aurinia Pharmaceuticals, Inc. (NASDAQ: AUPH) is a late-stage biopharmaceutical company focused on the development of the therapeutic immunomodulating drug candidate voclosporin for the treatment of lupus nephritis. The company leverages its team’s past clinical experience…

  • Atossa Genetics (ATOS) Presents at Rodman & Renshaw Conference

    Atossa Genetics Inc. (NASDAQ: ATOS) is focused on improving breast health through the development of innovative laboratory services, medical devices and therapeutics. The company’s laboratory services are being developed by its subsidiary, The National Reference…

  • AsteriasBiotherapeutics (AST) Presents at Rodman & Renshaw Conference

    AsteriasBiotherapeutics, Inc. (NYSE: AST) is a biotechnology company in the emerging field of regenerative medicine. The company’s proprietary, industry-leading platforms are based on its pluripotent stem cell and allogeneic dendritic cell technologies. Asterias is currently…

  • Ascent Solar Technologies (ASTI) Presents at Rodman & Renshaw Conference

    Ascent Solar Technologies, Inc. (NASDAQ: ASTI) is a developer of thin-film photovoltaic modules with substrate materials that are more flexible, versatile and rugged than traditional solar panels. By pioneering a technology that is recognized as…

  • Arno Therapeutics (ARNI) Presents at Rodman & Renshaw Conference

    Arno Therapeutics, Inc. (OTCQB: ARNI) is a clinical stage biopharmaceutical company developing innovative products for the treatment of cancer and other life threatening diseases. The company has exclusive worldwide rights to develop and market three…

  • Arch Therapeutics (ARTH) Presents at Rodman & Renshaw Conference

    Arch Therapeutics, Inc. (OTCQB: ARTH) is a medical device company developing a novel approach to stop bleeding and control leaking during surgery and trauma care. The company’s innovative self-assembling peptide technology platform has been shown…

  • ARCA biopharma (ABIO) Presents at Rodman & Renshaw Conference

    ARCA biopharma, Inc. (NASDAQ: ABIO) is dedicated to the development of genetically-targeted therapies for cardiovascular diseases. The company’s lead product candidate, bucindolol, is an investigational, pharmacologically unique beta-blocker and mild vasodilator being developed to treat…

  • Apricus Biosciences (APRI) Presents at Rodman & Renshaw Conference

    Apricus Biosciences, Inc. (NASDAQ: APRI) is a biopharmaceutical company advancing innovative medicines in urology and rheumatology. The company has initiated a phase IIb trial for fispemifene, a selective estrogen receptor modulator for the treatment of…

  • Aoxing Pharmaceutical Company (AXN) Presents at Rodman & Renshaw Conference

    Aoxing Pharmaceutical Company, Inc. (NYSE: AXN) is a specialty pharmaceutical company operating in China. The company specializes in the research, development, manufacture and distribution of a variety of narcotics and pain-management products. Aoxing currently operates…

  • Amyris (AMRS) Presents at Rodman & Renshaw Conference

    Amyris, Inc. (NASDAQ: AMRS) is an integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Through the application of its innovative bioscience solutions, the company is able to convert…

  • American Lorain (ALN) Presents at Rodman & Renshaw Conference

    American Lorain Corporation (NYSE: ALN) is an international processed snack foods, convenience foods and frozen foods company based in Shandong Province, China. The company recently announced the launch of a new breakfast product line, the…

  • AmpliPhi Biosciences (APHB) Presents at Rodman & Renshaw Conference

    AmpliPhi Biosciences Corporation (OTCQB: APHB) is a biotechnology company focused on the development and commercialization of novel bacteriophage-based antibacterial therapeutics. The company’s product development programs target infections that are often resistant to existing antibiotic treatments.…

  • American DG Energy (ADGE) Presents at Rodman & Renshaw Conference

    American DG Energy, Inc. (NYSE: ADGE) is a leading supplier of low-cost energy through the commercialization of its affordable distributed power generating systems. The company’s On-Site Utility™ energy solutions are available without any capital or…

  • Amarin (AMRN) Presents at Rodman & Renshaw Conference

    Amarin Corporation (NASDAQ: AMRN) is a biopharmaceutical company focused on the commercialization and development of therapeutics designed to improve cardiovascular health. The company’s product development program leverages its extensive experience in lipid science and the…

  • AlliquaBioMedical (ALQA) Presents at Rodman & Renshaw Conference

    AlliquaBioMedical, Inc. (NASDAQ: ALQA) is a leading provider of advanced wound care solutions. Through its sales and distribution network, the company provides a suite of technological products that enhance the wound care practitioner’s ability to…

  • Agile Therapeutics (AGRX) Presents at Rodman & Renshaw Conference

    Agile Therapeutics, Inc. (NASDAQ: AGRX) is a women’s health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products that provide women with greater convenience and facilitate compliance. The company’s lead…

  • Agenus (AGEN) Presents at Rodman & Renshaw Conference

    Agenus Inc. (NASDAQ: AGEN) is an immunology company focused on the discovery and development of novel checkpoint modulators, vaccines and adjuvants to treat cancer and other diseases. Using its proprietary platforms Retrocyte Display™ and SECANT®,…

  • Aethlon Medical (AEMD) Presents at Rodman & Renshaw Conference

    Aethlon Medical, Inc. (NASDAQ: AEMD) is a leading developer of affinity biofiltrationdevices to treat life-threatening diseases. The company’s lead therapeutic candidate, Aethlon Hemopurifier®, is a first-in-class device that targets the rapid elimination of infectious viruses…

  • AeternaZentaris (AEZS) Presents at Rodman & Renshaw Conference

    AeternaZentaris, Inc. (NASDAQ: AEZS) is a specialty biopharmaceutical company engaged in the development and commercialization of novel treatments in the fields of oncology, endocrinology and women’s health. The company’s product pipeline includes Macrilen™, which is…

  • Aemetis (AMTX) Presents at Rodman & Renshaw Conference

    Aemetis, Inc. (NASDAQ: AMTX) is an advanced renewable fuels and renewable chemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products. The company currently owns and operates a…

  • ADMA Biologics (ADMA) Presents at Rodman & Renshaw Conference

    ADMA Biologics, Inc. (NASDAQ: ADMA) is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disorder (PIDD) and certain infectious diseases.…

  • Actinium Pharmaceuticals (ATNM) Presents at Rodman & Renshaw Conference

    Actinium Pharmaceuticals, Inc. (NYSE: ANTM) is a biopharmaceutical company focused on the development of cancer drugs. The company’s product candidates are based on its patented technology, which combines the cancer targeting precision of monoclonal antibodies…

  • Acme United (ACU) Presents at Rodman & Renshaw Conference

    Acme United Corporation (NYSE: ACU) is a worldwide supplier of innovative cutting, measuring and safety products to the school, home, office, hardware, sporting goods and industrial markets. The company sells its products under a collection…

  • AcelRx Pharmaceuticals (ACRX) Presents at Rodman & Renshaw Conference

    AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain. The company’s leading product candidate, Zalviso™, is designed for the…